Johnson N, van Scherpenzeel R, Bakkers M, Ramamohan A, van Overveld D, Le L
Nat Commun. 2024; 15(1):5458.
PMID: 38937429
PMC: 11211449.
DOI: 10.1038/s41467-024-49757-1.
Liu Y, Chi M, Wen H, Zhao L, Song Y, Liu N
Virus Genes. 2019; 56(1):37-48.
PMID: 31768710
DOI: 10.1007/s11262-019-01713-8.
Matsunaga S, Kawakami S, Matsuo I, Okayama A, Tsukagoshi H, Kudoh A
Front Microbiol. 2014; 5:208.
PMID: 24860558
PMC: 4026691.
DOI: 10.3389/fmicb.2014.00208.
Roth J, Li J, Barnard D
Curr Protoc Microbiol. 2010; Chapter 15:Unit 15F.1.
PMID: 20440682
PMC: 2895816.
DOI: 10.1002/9780471729259.mc15f01s17.
Qiao D, Janke B, Elankumaran S
Virus Genes. 2009; 39(1):53-65.
PMID: 19337823
DOI: 10.1007/s11262-009-0353-2.
Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge.
Bukreyev A, Marzi A, Feldmann F, Zhang L, Yang L, Ward J
Virology. 2008; 383(2):348-61.
PMID: 19010509
PMC: 2649782.
DOI: 10.1016/j.virol.2008.09.030.
Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41.
Sanders R, Dankers M, Busser E, Caffrey M, Moore J, Berkhout B
Retrovirology. 2004; 1:3.
PMID: 15169554
PMC: 416572.
DOI: 10.1186/1742-4690-1-3.
Parainfluenza viruses.
Henrickson K
Clin Microbiol Rev. 2003; 16(2):242-64.
PMID: 12692097
PMC: 153148.
DOI: 10.1128/CMR.16.2.242-264.2003.
Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes.
Pinter A, Kopelman R, Li Z, Kayman S, Sanders D
J Virol. 1997; 71(10):8073-7.
PMID: 9311907
PMC: 192174.
DOI: 10.1128/JVI.71.10.8073-8077.1997.
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion.
Tanabayashi K, Compans R
J Virol. 1996; 70(9):6112-8.
PMID: 8709235
PMC: 190633.
DOI: 10.1128/JVI.70.9.6112-6118.1996.
Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene.
Ray R, Galinski M, Heminway B, Meyer K, Newman F, Belshe R
J Virol. 1996; 70(1):580-4.
PMID: 8523574
PMC: 189848.
DOI: 10.1128/JVI.70.1.580-584.1996.
Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.
Ray R, Meyer K, Newman F, Belshe R
J Virol. 1995; 69(3):1959-63.
PMID: 7853542
PMC: 188817.
DOI: 10.1128/JVI.69.3.1959-1963.1995.
The polypeptides of human parainfluenza type 2 virus and their synthesis in infected cells.
Ito Y, Tsurudome M, Hishiyama M
Arch Virol. 1987; 95(3-4):211-24.
PMID: 3038054
DOI: 10.1007/BF01310781.
Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map.
Spriggs M, Collins P
J Virol. 1986; 59(3):646-54.
PMID: 3016327
PMC: 253227.
DOI: 10.1128/JVI.59.3.646-654.1986.
3'-Terminal sequence of human parainfluenza virus 3 genomic RNA.
Dimock K, Rud E, Kang C
Nucleic Acids Res. 1986; 14(11):4694.
PMID: 3012476
PMC: 311477.
DOI: 10.1093/nar/14.11.4694.
Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein.
Elango N, Coligan J, Jambou R, Venkatesan S
J Virol. 1986; 57(2):481-9.
PMID: 3003381
PMC: 252760.
DOI: 10.1128/JVI.57.2.481-489.1986.
Production of monoclonal antibodies against parainfluenza 3 virus and their use in diagnosis by immunofluorescence.
Waner J, Whitehurst N, Downs T, Graves D
J Clin Microbiol. 1985; 22(4):535-8.
PMID: 3001131
PMC: 268462.
DOI: 10.1128/jcm.22.4.535-538.1985.
Proteins associated with human parainfluenza virus type 3.
Jambou R, Elango N, Venkatesan S
J Virol. 1985; 56(1):298-302.
PMID: 2993658
PMC: 252530.
DOI: 10.1128/JVI.56.1.298-302.1985.
Intracellular synthesis of human parainfluenza type 3 virus-specified polypeptides.
Wechsler S, Lambert D, Galinski M, PONS M
J Virol. 1985; 54(3):661-4.
PMID: 2987519
PMC: 254849.
DOI: 10.1128/JVI.54.3.661-664.1985.
Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.
Spriggs M, Collins P, Tierney E, London W, Murphy B
J Virol. 1988; 62(4):1293-6.
PMID: 2831389
PMC: 253140.
DOI: 10.1128/JVI.62.4.1293-1296.1988.